Rein Therapeutics Inc. (RNTX)
Market Closed
23 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 58
-0.02
-3.3223%
After Hours
$
+0.12 +20.2405% 0. 70
50.22M Market Cap
- P/E Ratio
- Div Yield
331,300 Volume
- Eps
$ 0.6
Previous Close Want to track RNTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rein Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JRP Jay R. Petschek Corsair Capital Management LP | 80,000 | $83,200 | $47,536 | -$35,664 | -42.87% |
| YA Yinka Akinsola Blue Trust Inc. | 20 | $35.4 | $11.57 | -$23.83 | -67.32% |
 Richard Slavik Newbridge Financial Services Group Inc. | 97 | $126.1 | $57.65 | -$68.45 | -54.28% |
 Tyler Glazier New Millennium Group LLC | 2,038 | $2,364.08 | $1,209.96 | -$1,154.12 | -48.82% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $1.33 | $0.57 | -$0.76 | -57.14% |
2026 © Marketlog. All Rights Reserved.
